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receptor-activity modifying protein (RAMP) 1 or 3. In this study, we aim to validate a CTR-floxed
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virus (AAV) containing a green fluorescent protein tag (GFP) and Cre recombinase to create a locally
restricted knockout of CTR in the caudal hindbrain. KO mice showed a lack of c-Fos expression, a
marker for neuronal activation, in AP, NTS and LPBN after amylin injection. The effect of amylin and
salmon calcitonin (sCT), an amylin receptor agonist, on food intake was blunted in KO mice, confirming
a functional reduction of amylin signaling in the hindbrain.
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A B S T R A C T
The area postrema (AP), located in the caudal hindbrain, is one of the primary binding sites for the endocrine satiation hormone amylin. Amylin is co-secreted with
insulin from pancreatic ß-cells and binds to heterodimeric receptors that consist of a calcitonin core receptor (CTR) paired with receptor-activity modifying protein
(RAMP) 1 or 3. In this study, we aim to validate a CTR-floxed (CTRfl/fl) mouse model for the functional and site-specific depletion of amylin/CTR signaling in the AP
and the nucleus tractus solitarius (NTS). CTRfl/fl mice were injected in the NTS with adeno-associated virus (AAV) containing a green fluorescent protein tag (GFP)
and Cre recombinase to create a locally restricted knockout of CTR in the caudal hindbrain. KO mice showed a lack of c-Fos expression, a marker for neuronal
activation, in the AP, NTS and LPBN after amylin injection. The effect of amylin and salmon calcitonin (sCT), an amylin receptor agonist, on food intake was blunted
in KO mice, confirming a functional reduction of amylin signaling in the hindbrain.
INTRODUCTION
Adeno-associated virus (AAV) vectors are a viable tool to study site-
specific alterations in central control of metabolism [17]. In this study,
we used an AAV that expresses Cre recombinase in its target cells under
the human synapsin 1 (hSyn1) promoter to remove the loxP-flanked
exons 6 and 7 of the calcitonin receptor (CTR) gene in CTRfl/fl mice [9].
CTR is the core component of the amylin receptor, which is a hetero-
dimer of CTR and receptor activity-modifying proteins (RAMP) 1-3 [4],
[18]. The genetic depletion of CTR in the target areas is expected to
affect all subtypes of the amylin receptor and diminish any effect of the
ligand conveyed through this receptor. Amylin is a peptide hormone,
co-released from the pancreas with insulin, and has direct central ef-
fects on food intake and energy expenditure by acting on noradrenergic
neurons in the area postrema (AP) and pro-opiomelanocortin (POMC)
and neuropeptide Y (NPY) neurons in the arcuate nucleus (ARC) [12],
[23], [20]. The effect of amylin on the AP to acutely reduce food intake
has been extensively studied [1], [10], [15] and amylin-induced c-Fos
has been demonstrated to be a marker of amylin's neuronal activation
in the AP and LPBN [2].
Hence, amylin's activation of c-Fos serves as a verification for suc-
cessful CTR depletion after AAV injection in CTRfl/fl mice. Although the
use of viral vectors in circumventricular organs comes with technical
difficulties, a recent study successfully applied shRNA-delivery into the
AP by injecting the virus into the adjacent nucleus of the solitary tract
(NTS) [27]. In this study, we use the same approach to allow AAV-Cre
expression in AP neurons for CTR depletion and measure the acute
effects of amylin and its agonist salmon calcitonin (sCT) on food intake
and c-Fos expression to quantify the loss of function.
MATERIAL AND METHODS
CTRfl/fl mice and housing
CTRfl/fl mice (Calcr<tm1(fl)>; MGI:5751436; frozen sperm was
kindly provided by Dr. Jean-Pierre David and Dr Thorsten Schinke,
University Medical Center Hamburg) [9] were bred for the experiment
and distributed into age-matched treatment groups. The animals were
kept in a controlled environment (21±2°C, 12/12 inversed light cycle)
and on a standard chow diet (3430, Provimi Kliba, Kaiseraugst, Swit-
zerland) for the entire experimental period. Three weeks of habitua-
tion/recovery were provided before and after surgery. Male mice were
single housed after surgery because of fighting while female mice were
single housed one week before the start of food intake measurements.
All procedures were approved by the Veterinary Office of the Canton
Zurich, Switzerland.
Ai14 reporter mice [B6.Cg-Gt(ROSA)26Sor<tm14(CAG-tdTomato)
Hze>/J(#007914)] were crossed with CTRfl/fl mice for pilot studies to
confirm stereotaxic coordinates and AAV-Cre induction. Expression of
Cre recombinase leads to the removal of a LoxP-flanked STOP cassette
that prevents CAG-promoter-driven transcription of red fluorescence
protein (tdTomato) in this reporter line [16].
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Surgical procedures for virus delivery
Nine- to fifteen-week-old male and female mice were anesthetized
by intraperitoneal injection of ketamine (Ketanarkon-100, Streuli
Pharma; 75mg/kg) and medetomidine (Medetor, Virbac; 0.75mg/kg).
The head was fixed with intraaural pins to a stereotaxic platform (KOPF
instruments, Tujunga, CA). Burr holes were drilled at the target co-
ordinates and a 35 G syringe (World precision instruments, Sarasota,
FL) was inserted for a bilateral injection of 0.8µl AAV-Cre or AAV-GFP
each. The target coordinates for the NTS were -7.5mm posterior for
males, 7.45mm posterior for females and 0.25mm lateral from bregma,
with a depth of 4.5mm, measured from the skull surface (modified from
[27]). Anesthesia was antagonized by intraperitoneal injection of ati-
pamezol (Revertor, Virbac; 3.75mg/kg). Mice received antibiotic and
analgesic treatment on surgery day and the following three days with
subcutaneous injections of enrofloxacin (Baytril, Bayer; 7.5mg/kg) and
meloxicam (Metacam, Boehringer Ingelheim; 1mg/kg).
Viral vectors for stereotaxic injection
Viral vectors were obtained from the repository of the core facility
at the University of Zurich and ETH: AAV-Cre (v146-8; ssAAV-8/2-
hSyn1-chI-EGFP_2A_iCre-WPRE-SV40p(A), physical titer 1.1*10E12
vg/ml) and AAV-GFP (v308-8; ssAAV-8/2-hSyn1-chI[4x(shNS)]-EGFP-
WPRE-SV40p(A), physical titer 4.1*10E12 vg/ml).
Food intake measurements
Mice were single-housed and adapted to food hoppers in BioDAQ
cages (Research Diets, New Brunswick, NJ) over a one-week period.
Baseline food intake was then measured for three days with ad libitum
access to chow. Food intake in response to amylin was assessed in a
crossover design with a three-day washout period, with intraperitoneal
injections of amylin (H-9475, Bachem, Bubendorf; 50, 500µg/kg) or
saline (NaCl 0.9%) at lights out after a 12h fast. Four female KO mice
Figure 1. Bilateral AAV injection in the NTS leads to functional cre induction and the depletion of CTR in the AP. Virus design of AAV-GFP, containing a neuron-
specific hSyn1 promoter and a scrambled nonsense sequence followed by GFP (A). AAV-Cre design with the same hSyn1 promoter, followed by GFP and improved
Cre (iCre), which are separated by self-cleaving peptide 2A (B Viral Vector Facility, UZH). 20X representative AP images of CTRfl/fl x Ai14Tg/+ mice injected with the
AAV-GFP (control) or AAV-Cre (KO) with GFP in green and immunostaining of CTR in cyan (C, left). AP sections overlayed with red fluorescence channel reveal
tdTomato expression in AAV-Cre-injected CTRfl/fl x Ai14Tg/+ mice (C, right). CTR-positive GFP cells are indicated with arrowheads. AP = area postrema, limited by
dashed lines; cc = central canal; inlays are zoomed in 2X. Experimental timeline for Cre reporter mice (D, top) which are shown in (C). After evaluation of this pilot
experiment, the study was continued with CTRfl/fl mice using a longer recovery period and slightly modified stereotaxic coordinates (D, bottom). Four mice were
excluded at week 7 due to clinical signs of discomfort.
B. Coester, et al. Physiology & Behavior 223 (2020) 112992
2
were excluded from the following measurements after displaying clin-
ical symptoms of discomfort or maladaptation to single housing. The
food intake after the CTR agonist -sCT (4033011.0001, Bachem; 10µg/
kg i.p.) was measured at the end of the study in the remaining animals
to exclude interference of this longer acting CTR agonist with other
measurements. Individual meals were defined with an inter-meal in-
terval of ≥600s and a meal size of ≥0.02g [7].
Perfusion and brain processing
Mice were fasted for 12h during the light phase and injected with
amylin (50µg/kg i.p.) at dark onset 90 minutes prior to perfusion. After
terminal anesthesia with pentobarbital (Kantonsapotheke Zurich,
Switzerland; 200mg/kg i.p.), mice were perfused intracardially with
cold 0.1M phosphate buffer (PB) for 1.5min followed by 4% paraf-
ormaldehyde (PFA) in PB for 2.5min. The brains were postfixed for 24h
in 4% PFA and cryoprotected for 24h in 30% sucrose before being
frozen in hexane on dry ice for storage at -80°C. Sections of 20µm were
cut on a cryostat (CM3050S, Leica Biosystems, Germany), mounted on
Superfrost Plus slides (Thermo Fisher Scientific, Reinach, Switzerland)
and cryoprotected in 50% 0.02M potassium phosphate buffered saline
(KPBS), 30% ethylene glycol, 20% glycerol for storage at -20°C.
Immunohistochemistry
c-Fos IHC of AP, NTS and LPBN (Fig. 4): Brain sections were rinsed
five times in 0.02M KPBS before an overnight block in 5% normal goat
serum (NGS) + 0.4% Triton in KPBS at 4°C. The sections were then
placed in primary antibody solution (1:500 rabbit anti-c-Fos, Cell Sig-
naling #2250 in KPBS + 0.4% triton and 2% NGS) for 48h at 4°C. After
five rinses in KPBS, sections were placed in secondary antibody solution
(1:100 goat anti-rabbit Cy3, Jackson #111-165-144 in KPBS + 0.4%
triton and 2% NGS) for 2h at room temperature (RT). Sections were
counterstained with DAPI (0.25µg/ml, 5min at RT) and cover-slipped
with vectashield (Vector Laboratories).
CTR IHC of AP and NTS (Fig. 1): Brain sections were rinsed five
times in 0.01M PBS + 0.1% triton, blocked for 2h at RT in 3%
NGS + 0.3% triton in PBS and placed in primary antibody solution
(1:500 rabbit anti-CTR, Abcam #ab11042+0.3% triton) for 48h at 4°C.
After two rinses in PBS and one rinse in PBS + 0.1% triton, sections
were placed in secondary antibody solution (1:250 goat anti rabbit 647,
Invitrogen #A-21245 + 0.3% triton) for 2h at RT and counterstained
with DAPI [7].
CTR IHC for quantification (Fig. 5): The sections for CTR quantifi-
cation were stained with a modified protocol that includes antigen re-
trieval (0.01M citric acid pH 6 + 0.05% Tween 20 in steamer for 20
min) and amplification of secondary antibodies (1:1000 biotinylated
goat anti rabbit, Vector #BA-1000 + 0.3% triton for 2h at RT, three
rinses with PBS + 0.1% triton, 1:1000 streptavidin-647, Invitrogen
#S21374 + 0.3% triton for 2h at RT) to increase sensitivity [5].
Imaging and quantification
Immunostained sections were visualized with an Axio Imager 2
Figure 2. Body weight development and meal patterns after AAV-injection do not differ between control and KO mice. Body weight (A) and body weight gain (B) of
9- to 15-week-old CTRfl/fl mice after being injected with AAV-control-GFP or AAV-Cre. Five weeks after surgery, mice were single-housed into BioDAQ cages for food
intake analysis. Meal size (C), meal duration (D) and number of meals (E) were recorded and averaged over a three-day period with ad libitum access to chow diet.
Values are represented as mean±SEM; n=2-3 males and 7-9 females per group. No significant differences between KO and control groups were found after mixed-
effects analysis for repeated and matched values (A-B) or two-way repeated measure ANOVA with Sidak's multiple comparisons test (C-E).
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microscope (Zeiss Germany) and three sections of AP/NTS (bregma
-7.31 to -7.55) and LPBN (bregma -5.19 to -5.33) per animal were re-
corded for cell counting. Grayscale pictures of c-Fos staining (Fig. 4)
were converted to binary with a pre-defined threshold in ImageJ and
positive cells were counted with the “analyze particles” utility
(size = 10-infinity; circularity 0.10-1.00) [26]. Pictures of CTR staining
(Fig. 5) were quantified by manual annotation to exclude fibers and
only count cell bodies.
Statistics
All data was analyzed with Prism 8 (GraphPad, La Jolla, CA). Body
weight data was separated by sex and analyzed with a mixed effects
model for repeated measures and matched values (Fig. 2A-B). Meal
patterns were analyzed using repeated measure analysis of variance
(ANOVA) and multiple comparisons with Sidak correction (Fig. 2C-E).
Food intake data was analyzed with two-way ANOVA and multiple
comparisons with Bonferroni's correction (Fig. 3). Cell quantifications
for c-Fos and CTR were analyzed with two-way ANOVA and multiple
comparisons with Sidak's correction (Fig. 4B, 4D, 5B). Correlations of
CTR quantification and food intake or meal patterns were analyzed by
simple linear regression (Fig. 5 C-F). Grouped data are expressed as
mean± SEM with individual data points indicated, and any statistically
significant differences between groups are indicated by asterisks
(*p<0.05, **p<0.01, *** p<0.001, ****p <0.0001), non-significant
trends are annotated with the exact p value. Results of simple linear
regression analysis are individually annotated.
RESULTS
Bilateral NTS injections allow Cre-mediated recombination in the AP
9-week-old CTRfl/fl x Ai14Tg/+ mice were injected with AAV-GFP
(control; Fig. 1A) or AAV-Cre (KO; Fig. 1B), respectively. Both groups
show robust GFP expression at the injection site in a pilot experiment
two weeks after surgery (Fig. 1C and D, top). AAV-Cre-injected mice
additionally show tdTomato fluorescence in the AP following Cre-
mediated recombination, which confirms expression of Cre re-
combinase after virus injections. CTR immunohistochemistry revealed
no co-localization of CTR fibers with tdTomato/GFP-positive cells in KO
mice and abundant co-localization of CTR fibers with GFP in control
mice (Fig. 1C). The adjacent NTS also shows robust GFP expression but
little detectable CTR immunofluorescence.
Mice retain a stable body weight after virus injection
9- to 15-week-old male and female CTRfl/fl mice underwent surgery
for virus injection and were allowed to recover for three weeks. Male
mice had to be single housed after surgery because of aggression, fe-
male mice stayed in group housing until the food intake measurements
6 weeks after surgery (Fig. 1D). There was no significant difference in
body weight or body weight gain between treatment groups (Fig. 2A-B).
Meal patterns at week 6 after surgery were analyzed in a three-day
average by number of meals, average meal size and average meal
duration, but no significant effects were found when comparing KO to
control groups under baseline conditions (Fig. 2C-E). When CTR ex-
pression and meal duration were correlated in the KO group only, meal
duration was significantly increased when CTR was depleted (Fig 5C).
KO mice are insensitive to amylin and salmon calcitonin injections
When KO mice are compared to control mice after injection of
amylin (50 or 500µg/kg) or sCT (10µg/kg), there is a significant effect
for genotype in 4-hour cumulative food intake (Fig. 3C) and a non-
significant trend for treatment effect at 4 and 12 hours after injection
(Fig. 3C-D). When cumulative food intake is calculated as percentage of
saline, a significant effect between genotypes is observed at 2, 4 and
12h after injection (Fig. 3F-H). Post-hoc analysis shows that the geno-
type effect is mainly driven by a higher food intake of KO mice after sCT
injection (Fig. 3G-H).
Figure 3. KO mice do not reduce their food intake after intraperitoneal injections of amylin and salmon calcitonin (sCT). Mice were fasted overnight and injected
with saline, amylin 50µg/kg (Amy50) or amylin 500µg/kg (Amy500) in a crossover study with a three-day washout period between injections (A-H). A separate
round of injections was conducted with salmon calcitonin 10µg/kg (sCT10). Food intake was recorded for the following 12h and is expressed as cumulative food
intake over time (A-D) and as a percentage of saline control (E-H). Values are represented as mean±SEM; n = 2-3 males and 7-9 females per group; four KO females
had to be excluded before the sCT measurements due to maladjustment to single housing (AAV-Cre sCT10, n = 3 females and 2 males). * p<0.05, ** p<0.01; after
two-way ANOVA with Bonferroni's multiple comparisons test (Gen); dashed line = 100%.
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c-Fos expression in response to amylin is abolished in the AP, NTS and LPBN
of KO mice
Amylin injections (50µg/kg) after overnight fasting elicit a strong c-
Fos response in the AP and NTS of control but not KO mice (Fig. 4A-B).
Both groups show robust GFP expression 8 weeks after virus injection,
but only control mice show c-Fos expression in GFP-labelled cells after
amylin injections (Fig. 4A). GFP-labelled neuronal fibers are also pre-
sent in the LPBN, a downstream nucleus of amylin signaling in the
hindbrain (Fig. 4C). LPBN c-Fos expression after amylin injection is
significantly increased in control mice but not in KO mice compared to
saline (Fig. 4D).
Depletion of CTR correlates with increased food intake after amylin injection
and increases meal duration
AP and NTS were stained for CTR to quantify expression at the end
of the study (Fig. 5A). Quantification of CTR at the end of the study
showed a successful depletion in 56% of the animals for the AAV-Cre
group (Fig. 5A-B). Histograms of CTR+ cells in the AP showed two
clusters that were separated into “Hit” and “Non-Hit” groups to exclude
data of KO mice with abundant CTR expression from grouped analyses
(Fig. 5B). Quantification of CTR in the NTS revealed only sparse ex-
pression in all groups. Correlation of CTR+ cells with meal pattern data
showed a significant association of CTR depletion and meal duration,
but not meal number (Fig. 5C). KO mice injected with amylin showed a
significant association of CTR depletion and food intake at 2h post-in-
jection (50µg/kg; Fig. 5E) and this correlation was highly significant at
2h and 4h after a higher dose of amylin (500µg/kg; Fig. 5F).
DISCUSSION
In this study, we aimed to validate the site-specific depletion of CTR
using AAV-Cre in a CTRfl/fl mouse model to confirm a functional re-
duction of amylin signaling after the loss of CTR in AP neurons. This
pathway was chosen because all necessary amylin receptor components
are present in single AP neurons [10] and downstream signaling to the
LPBN has been linked to feeding-related changes after amylin injection
[29]. The pharmacological depletion of amylin signaling or lesion of the
AP increase food intake and abolish amylin-induced food intake re-
duction [14], [19].
In a first experiment, an Ai14 Cre reporter mouse was crossed with
CTRfl/fl and injected with AAV-Cre virus into the NTS to assess Cre
expression in the AP. The AAV-Cre virus codes for both GFP and Cre
Figure 4. KO mice show no significant in-
crease of c-Fos-positive cells after amylin in-
jection in the AP and LPBN. Mice were fasted
overnight and injected with saline or amylin
(50µg/kg) 90 minutes prior to sacrifice.
Immunohistochemistry of c-Fos was quantified
for three sections per animal in the AP and NTS
(B) and LPBN (D). AP (A) or LPBN 20X (C)
representative images for AAV-control and
AAV-Cre (KO) mice with c-Fos IHC (red) and
GFP (green); double-labelled cells are in-
dicated with arrowheads. Values are re-
presented as mean±SEM; n = 2-3 males and
7-9 females per group. * p<0.05, ** p<0.01,
**** p<0.0001 after two-way ANOVA with
Sidak's multiple comparisons test; AP = area
postrema, LPBN = lateral parabrachial nu-
cleus, limited by dashed lines; cc = central
canal; scp = superior cerebellar peduncle.
Inlays are zoomed in 2X.
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recombinase, separated by self-cleaving peptide 2A, while AAV-GFP
only codes for GFP. The relative intensity of GFP and tdTomato fluor-
escence is variable, since the former depends on the initial transfection
and the latter depends on CAG-promoter-driven expression after the
LoxP-flanked STOP-cassette is removed (i.e. successful Cre-mediated
recombination) [16].
Earlier experiments with direct injection into the AP have been
mostly unsuccessful, probably due to insufficient retainment of virus
suspension in the circumventricular organ, which is heavily vascular-
ized. A recently published study by [27] took a different approach by
injecting the virus into the adjacent nucleus of the solitary tract (NTS).
The retainment in the NTS and diffusion into the AP seem to be more
successful for the transfection of AP neurons. The Ai14 reporter line
confirmed Cre recombination in AP neurons even in cells where GFP
expression was faint, but diffusion to the AP was weak in the central
part. The reason for this was determined to be a rostral offset of the
injection site in the pilot experiment, therefore bregma coordinates
were adjusted by 220 µm caudally for the main study.
Body weight of the mice was stable throughout the study and no
difference between groups was found at the end of the study when all
mice had fully regained their initial body weight. Surprisingly, there
was no effect of CTR knockout in AP/NTS on meal patterns unlike full
body knockout of RAMP1/3, that results in fewer, but larger and longer
meals [6]. Since these effects observed in RAMP 1/3 KO mice appear to
be stronger in male mice, they could be masked in this study where we
predominantly used female mice. Interestingly, when CTR depletion
was correlated with meal patterns in the AAV-Cre group, we observed
that the CTR depleted animals had significantly longer meals, which is
in line with previous data and confirms the function of amylin as a
satiation factor [13].
Cumulative food intake after overnight fasting and refeeding with
injections of amylin (50 and 500µg/kg) seemed to be initially reduced
in KO mice in the first hour, but these trends are difficult to interpret
due to the high variance of 1h food intake in mice. At 2h and 4h, where
we usually observe an effect of amylin on food intake [6], KO mice
showed no response to amylin or sCT. Conversely, amylin and sCT
significantly decreased food intake in control mice when expressed as
percent of saline control. These observations can be recapitulated when
correlating CTR depletion with food intake after amylin injection in
AAV-Cre mice. Depleting CTR significantly correlated with increased
food intake after 2h and 4h following the higher dose of amylin and 2h
after the lower dose of amylin, further confirming the role of amylin
AP/NTS signaling as a major hub for meal termination [11]. As for sCT,
this regression analysis is inconclusive due to the exclusion of four fe-
male KO mice prior to the measurement. All four excluded mice were
CTR-depleted (i.e. in the AAV-Cre “Hit” group) and showed signs of
maladaptation to single housing. We could hypothesize that due to the
previously proposed anxiolytic properties of amylin [25], these KO
mice were more susceptible to stress and had increased anxiety.
Since amylin is known to elicit a strong c-Fos response in AP/NTS
neurons, amylin injections 90 minutes prior to sacrifice are routinely
used to quantify amylin signaling histologically [21]. GFP expression in
the AP/NTS was robust in both groups and there was virtually no
overlap of GFP and c-Fos in the KO group. Quantification of c-Fos in the
AP and NTS confirmed that KO mice do not respond to amylin injec-
tions with a measurable increase of c-Fos-positive cells. The LPBN re-
ceives projections from AP neurons [24], [22] and GFP-positive fibers
encapsulating second-order neurons were found in the dorsal and ex-
ternal part of the LPBN. Control mice showed a significant increase in c-
Fos-positive cells after amylin injection while KO mice only show a
marginal increase, which confirms a functional depletion of amylin
signaling in the hindbrain axis.
The quantification of c-Fos does not always completely correlate to
the food intake data [7], [28], and since c-Fos does not directly depict
amylin action in the AP, it is possible that a marginal activation is
overlooked with this method [21]. However, the analysis of food intake
after amylin injection was more sensitive (i.e. may be observed at lower
doses) when CTR depletion in AAV-Cre mice was compared to food
Figure 5. Quantification of CTR in the AP and correlation with food intake and meal patterns. Brains of all study animals were stained for CTR and positive cells were
counted in three representative AP/NTS sections per animal (A). AAV-Cre (KO) mice were then split into “non-hit” (n=7) and “hit” (n=9) as shown in the histogram
for CTR+ cells in the AP (B, left). Histogram for CTR+ cells in the NTS (B, middle) and summary data of CTR quantification (B, right). Baseline meal number and
meal duration (min/meal) for 12h dark phase ad libitum food intake was correlated with the number of CTR+ cells in the AP for all AAV-Cre mice (C). The same
approach was used to correlate 2h and 4h cumulative food intake of AAV-Cre mice after saline (D), amylin 50µg/kg (E) and amylin 500µg/kg (F) with CTR+ cells in
the AP. Simple linear regression analysis (C-F): goodness of fit (R2) and significance of non-zero slope (p) are indicated. AP= area postrema, limited by dashed lines;
cc = central canal; inlays are zoomed in 2X. **** p<0.0001 after Brown-Forsythe and Welch ANOVA tests for unequal SDs.
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intake, and it showed a significant effect of the lower amylin dose
(50µg/kg) that was also used for c-Fos. It seems that this internal
control unintendedly worked better than the actual AAV-control group
and therefore the non-significant trends in grouped analyses are just
lacking statistical power due to the small effect size. The reason for this
is possibly the wider distribution of CTR+ cell abundance in AAV-
control mice, which had a significantly higher variance compared to the
AAV-Cre group.
Overall, these data confirm that bilateral injections of AAV in the
NTS are a valuable technique to avoid previous issues with viral in-
jection into circumventricular organs like the AP. The successful viral
depletion of CTR shows that CTRfl/fl mice can be used for site- and cell
type-specific knockouts of CTR to study central amylin signaling path-
ways. The problem remains that this approach does not allow a dis-
tinction between AP and NTS that would allow a confirmation of NTS
specific effects of CTR, as it was proposed in a recent study [3]. This is
especially intriguing since we see only sparse CTR expression in the NTS
of CTRfl/fl mice, which suggests that NTS neurons are mainly indirectly
activated by amylin in this mouse model. Moreover, the use of Cre
driver lines might obscure that CTR expression is subject to post-
translational regulation. We have previously shown that the knockout
of RAMP 1/3 and RAMP 3 alone is sufficient to reduce CTR expression
in the AP [6].
The meal pattern data highlights that not all phenotypic effects of
RAMP1/3 KO can be directly reproduced with site-specific CTR KO.
Possibly, the unconditional RAMP1/3 KO affects more than just the
hindbrain signaling of amylin [8], and meal patterns could be influ-
enced by other brain areas.
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